A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy. (Q39203783)
Jump to navigation
Jump to search
scientific article published on 24 January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy. |
scientific article published on 24 January 2013 |
Statements
A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy (English)
Lu Dai
Yuqing Liu
Junyang Liu
Xiaoming Wen
ZhengShuang Xu
Zhuo Wang
Hong Sun
Shoubin Tang
Junmin Quan
Hui Zhang
24 January 2013